Daewoong, Wyeth are at odds over new drug agreement

Daewoong Pharm said on November 30 the company plans to appeal the International Arbitration Court over the dispute arising from the Wyeth Pharmaceutical’s unilateral cancellation of the contract between a biopharmaceutical company in Scotland and Daewoong.

According to Daewoong, the Scotland based company entered into an agreement with Daewoong to develop a novel infective agent in August 2...